Skip to content

News

High Park announces agreement to supply Yukon Liquor Corporation with non-medical cannabis

High Park announces agreement to supply Yukon Liquor Corporation with non-medical cannabis

Tilray announced today that we’ve signed an agreement with the Yukon Liquor Corporation to supply the territory with a diverse array of cannabis products in anticipation of legalization later this year. Tilray will fulfill the agreement through its affiliate High Park Company, which was formed to produce and distribute a broad-based portfolio of adult-use cannabis […] Read more »

High Park announces agreement to supply Société des alcools du Québec (SAQ) with cannabis

High Park announces agreement to supply Société des alcools du Québec (SAQ) with cannabis

Tilray Canada Ltd. announced today that the company has signed an agreement with the Société des alcools du Québec (SAQ) to supply the Québec market with high-quality cannabis brands and products in anticipation of adult-use legalization later this year. Tilray will fulfill the agreement through its affiliate High Park Company, which was formed to produce […] Read more »

Tilray launches High Park Company to produce and distribute adult-use cannabis in Canada

Tilray launches High Park Company to produce and distribute adult-use cannabis in Canada

In anticipation of the historic legalization of adult-use cannabis in Canada, Tilray today announced the creation of wholly-owned subsidiary High Park Company to produce and distribute a broad-based portfolio of cannabis brands and products. The company also announced that it is making an investment of up to $10 million in a new facility located in […] Read more »

Tilray shares update on pediatric epilepsy clinical trial

Tilray shares update on pediatric epilepsy clinical trial

You might have heard about the clinical trial Tilray is supporting at the Hospital for Sick Children (SickKids) in Toronto. The trial is studying how children with Dravet Syndrome, a rare and debilitating form of epilepsy, respond to adjunct therapy with a high-CBD medical cannabis extract that Tilray developed for the trial. Although the trial […] Read more »

New look for Tilray products

New look for Tilray products

Today in the Tilray Shop, you’ll see new labels on our suite of high-CBD, high-THC and CBD-THC balanced cannabis oils. CBD-dominant products are labeled in blue, while THC-dominant products are labelled in orange. Balanced THC-CBD products are indicated with a silver label. Target cannabinoid content is stated in bold letters on the front of the […] Read more »

Tilray signs Letter of Intent to supply Pharmasave

Tilray signs Letter of Intent to supply Pharmasave

Tilray Canada Ltd. announced today that we’ve entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada. Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products […] Read more »